TG Therapeutics Inc. (NASDAQ:TGTX) went up by 5.47% from its latest closing price compared to the recent 1-year high of $41.00. The company’s stock price has collected 19.64% of gains in the last five trading sessions.
Is It Worth Investing in TG Therapeutics Inc. (NASDAQ :TGTX) Right Now?
Plus, the 36-month beta value for TGTX is at 2.18.
TGTX currently public float of 132.72M and currently shorts hold a 14.50% ratio of that float. Today, the average trading volume of TGTX was 3.14M shares.
TGTX’s Market Performance
TGTX stocks went up by 19.64% for the week, with a monthly drop of -14.89% and a quarterly performance of -53.51%, while its annual performance rate touched -87.79%. The volatility ratio for the week stands at 10.50% while the volatility levels for the past 30 days are set at 12.09% for TG Therapeutics Inc. The simple moving average for the period of the last 20 days is 5.38% for TGTX stocks with a simple moving average of -71.98% for the last 200 days.
Analysts’ Opinion of TGTX
Many brokerage firms have already submitted their reports for TGTX stocks, with BofA Securities repeating the rating for TGTX by listing it as a “Underperform.” The predicted price for TGTX in the upcoming period, according to BofA Securities is $5 based on the research report published on May 20th of the current year 2022.
B. Riley Securities, on the other hand, stated in their research note that they expect to see TGTX reach a price target of $35, previously predicting the price at $49. The rating they have provided for TGTX stocks is “Buy” according to the report published on February 23rd, 2022.
Goldman gave a rating of “Sell” to TGTX, setting the target price at $26 in the report published on November 15th of the previous year.
TGTX Trading at -22.95% from the 50-Day Moving Average
After a stumble in the market that brought TGTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -88.71% of loss for the given period.
Volatility was left at 12.09%, however, over the last 30 days, the volatility rate increased by 10.50%, as shares sank -5.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.18% lower at present.
During the last 5 trading sessions, TGTX rose by +19.64%, which changed the moving average for the period of 200-days by -84.61% in comparison to the 20-day moving average, which settled at $4.38. In addition, TG Therapeutics Inc. saw -75.63% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at TGTX starting from Power Sean A, who sale 9,653 shares at the price of $18.31 back on Jan 05. After this action, Power Sean A now owns 568,483 shares of TG Therapeutics Inc., valued at $176,746 using the latest closing price.
WEISS MICHAEL S, the CEO and President of TG Therapeutics Inc., sale 30,671 shares at $18.31 during a trade that took place back on Jan 05, which means that WEISS MICHAEL S is holding 10,988,021 shares at $561,586 based on the most recent closing price.
Stock Fundamentals for TGTX
Equity return is now at value -118.50, with -83.00 for asset returns.